Clinical Trials
7 trialsNCT02487849 2020-03-04
HIPEC
Krankenhaus Barmherzige Schwestern Linz
Phase 2 Withdrawn
NCT01766622 2019-12-04
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT00005645 2018-09-18
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
Sanofi
Phase 2 Withdrawn
NCT00003865 2017-07-13
Toremifene in Treating Patients With Ovarian Cancer
George Washington University
Phase 2 Withdrawn
NCT00085527 2013-09-05
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
University of Chicago
Phase 2 Withdrawn
NCT00006267 2013-07-09
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Withdrawn
NCT00369954 2013-06-10
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
GOG Foundation
Phase 2 Withdrawn